--- title: "Dextra Corporate Advisors | M&A Advisor Barcelona" description: "Independent mid-market M&A boutique. Sell-side and buy-side for Spanish companies €5–50M. Founding partners on every mandate." canonical: https://dextracorporate.com/en/ lang: en --- ![](/images/hero-home.avif) Barcelona · Independent Boutique · Mid-Market M&A # The M&A advisor who has been in your place We advise business owners, funds and companies on sales, acquisitions, valuations and capital raises in the Spanish mid-market. As investors through our own funds (Gemba, Atalaya), we understand every deal from both sides of the table. [Confidential consultation](#contact) [Our services](#services) 70 _+_ Cumulative years in M&A 60 _+_ Transactions and deals closed 30 _+_ International offices CFA Worldwide network 5 Continents CFA Worldwide global network 1.000 €M+ in deals advised Why Dextra Corporate ## Four principles that define us. Four principles that coexist in every one of our mandates: the human component before and throughout the process, first-person execution, access to an independent global network, and the investor's perspective that understands every deal from the inside. Human process ### Managing the human component Selling your company is a personal and professional decision that carries significant emotional weight. We accompany the business owner throughout the entire process, attending at every moment to the psychological aspects these journeys entail. Senior-led ### 100% senior execution The partner who signs the mandate leads and actively participates in its execution from start to finish, supported by a team of high-calibre professionals trained at Dextra. CFA Worldwide Member ### Independent global network Members of CFA Worldwide, one of the world's largest independent M&A networks. 30+ offices across five continents, with no conflicts of interest with banks. Gemba + Atalaya ### We invest our own capital alongside clients Through, among others, the Gemba and Atalaya funds, we invest our own money alongside entrepreneurial families. We advise from the real experience of knowing what it means to invest own capital. Services ## Six practices across different sectors. We structure every mandate around a responsible partner from the first point of contact through to the close of the transaction or engagement. We understand that each service to each company is unique and relevant to that specific client. [View all services→](/en/services/) ### Company sale We guide business owners through the sale of their company: we structure the deal, value the company, manage the process of contacting and negotiating with buyers, and advise through to closing. [Learn more →](/en/services/venta-de-empresa/) ### Acquisitions Target search for companies with an inorganic growth strategy. Structuring, valuation, offer submission and negotiation through to completing the acquisition. [Learn more →](/en/services/compra-de-empresa/) ### Valuations Independent valuations applying market methodologies, in the context of an M&A transaction, shareholder dispute, refinancing or asset distribution, among others. Learn more → ### Debt advisory Debt advisory, refinancing and financial restructuring for our clients. We advise on the search and negotiation of bank and alternative financing. [Learn more →](/en/services/asesoramiento-deuda/) ### Management incentive plans MIP design in M&A contexts: key talent retention, interest alignment and executive committee support throughout the transaction. Learn more → ### Corporate advisory Ongoing corporate advisory: portfolio companies, mediation, strategic analysis and recurring board-level support. Learn more → Credentials ## Transactions that speak for themselves. It has been many decades now that we have been executing M&A transactions in the Spanish mid-market, with repeat clients across several sectors. [View all credentials→](/en/credentials/) 2025 December 2025 Buy-side Advisor to business group ![Palex Medical](/images/credenciales/palex.avif) Palex Medical on the acquisition of Equipamientos Sanitarios 2025 July 2025 Advisory Structuring and capital raising for a confidential build-up project in the food sector 2025 June 2025 Sell-side Advisor to the shareholders of Entitats Mèdiques Mollet and Brisalin Dental on the sale of 100% of its share capital to ![Cerba International](/images/credenciales/cerba.avif) Cerba International 2025 June 2025 Buy-side Advisor to business group ![Palex Medical](/images/credenciales/palex.avif) Palex Medical on the acquisition of Artur Salgado 2025 April 2025 Advisory Advisor to ![Antonio Matachana, S.A.](/images/credenciales/matachana.avif) Antonio Matachana, S.A. on the valuation of a foreign company, a potential acquisition target and manufacturer of medical and sterilization equipment 2024 May 2024 Buy-side Advisor to ![Palex Medical](/images/credenciales/palex.avif) Palex Medical on the acquisition of ![Normedan](/images/credenciales/normedan.avif) Normedan 2024 January 2024 Buy-side Advisor to the management team of ![Palex Medical](/images/credenciales/palex.avif) Palex Medical on the acquisition of ![Arium Medical](/images/credenciales/arium.avif) Arium Medical 2023 December 2023 Advisory Advisor to the management team of ![Palex Medical](/images/credenciales/palex.avif) Palex Medical on the sale of a majority stake to private equity fund ![Apax Partners](/images/credenciales/apax.avif) Apax Partners 2023 September 2023 Buy-side Advisor to business group ![Cegid](/images/credenciales/cegid.avif) Cegid on the acquisition of 100% of the share capital of ![Revo](/images/credenciales/revo.avif) Revo 2023 June 2023 Sell-side Advisor to the shareholders of Entitats Mèdiques Salou ![MediQ Salut](/images/credenciales/mediqsalut.avif) MediQ Salut on the sale of 100% of its share capital to ![Cerba](/images/credenciales/cerba.avif) Cerba 2023 June 2023 Financing & debt Advisor to the shareholders of ![Parking Pizza](/images/credenciales/parking-pizza.avif) Parking Pizza on the financing of its business expansion plan 2023 May 2023 Sell-side Financial advisor to ![HTBA](/images/credenciales/htba.avif) HTBA on the sale of its Animal Nutrition Aromas division to ![ITPSA](/images/credenciales/itpsa.avif) ITPSA Investment vehicles ## We don't just advise on deals: _we invest our own money._ Gemba Private Equity and Atalaya Hotels are the most recent vehicles we have managed and for which we have carried out investments, backed by capital from entrepreneurs, private investors and family offices. [Learn about Gemba](#contact) Gemba ### Industrial companies 6 €60–70M aggregate revenues Atalaya ### Hotel assets 4 900+ rooms Team ## Founding partners. The same team since 2012. The same team at every phase of the process. The partners who sign the mandate are the ones who lead its execution, with Big 4 credentials and over three decades of experience in the Spanish mid-market M&A. [Meet Dextra Corporate→](/en/team/) ![Stephan Koen — Founding partner](/images/equipo/stephan-koen-profile.avif) Founding Partner ### Stephan Koen ESADE MBAEx-Big 430+ years in M&A [View full profile →](/en/team/stephan-koen/) ![Iker Zabalza — Founding partner](/images/equipo/iker-zabalza-profile.avif) Founding Partner ### Iker Zabalza Eckerd CollegeEx-Big 420+ years in M&A [View full profile →](/en/team/iker-zabalza/) ![Dextra Corporate Advisors team](/images/equipo-consolidado.avif) Team ### The Dextra team Senior-led, no team rotation. Every transaction is executed by the partners who sign the mandate, supported by the director and the rest of the team. [Meet the team →](/en/team/) News ## We think out loud about the market and the dynamics of M&A. [View all articles→](/en/news/) [ ![](/images/salud.avif) ](/en/news/medtech-distribution-private-equity/) Private Equity 13 October 2026 [ ### Medtech distribution: why private equity buys companies that don't make the product ](/en/news/medtech-distribution-private-equity/) The European medical technology market exceeds €170 billion and, in southern Europe, still reaches hospitals through distributors. Why that channel has become a consolidable asset for private equity, and what drives the price of a mid-sized distributor when the buyer is a platform. [ ![](/images/oficina.avif) ](/en/news/management-team-value-lever/) Perspective 7 July 2026 [ ### The Team as a Value Lever: Why Preparing the Organisation Moves the Price ](/en/news/management-team-value-lever/) The management team is one of the variables that most moves a buyer's offer in the mid-market. Why preparing it twelve to twenty-four months in advance translates into a better price and better terms. [ ![](/images/m&a.avif) ](/en/news/buy-and-build-private-equity-midmarket/) Private Equity 30 June 2026 [ ### Buy-and-Build in Spain: How Private Equity Is Building the Mid-Market ](/en/news/buy-and-build-private-equity-midmarket/) Add-ons now exceed 75% of global buyout activity. Why the most likely buyer in the Spanish mid-market in 2026 is a fund building a platform — and what changes depending on whether your company is a platform or an add-on. FAQs ## We answer your most common questions. The questions every business owner asks when considering selling, buying, financing or restructuring the company's capital. [View all questions→](/en/faq/) Between 6 and 12 months from mandate signing to closing. In well-prepared mandates (vendor due diligence + audited data room) the competitive process can close in 6–8 months. In companies without prior preparation, organising information can add 1–2 months before going to market. We align our interests with our client's, structuring fees primarily on a success basis, combined with a capped monthly fixed fee. Fully transparent fees: any remuneration is set out in writing and signed in the mandate. The success fee is only earned if a transaction takes place. Iberian mid-market, typically companies with EV between €10M and €150M. We work with family groups, corporates and private equity fund managers. Yes. Through the CFA Worldwide network (30+ offices across five continents) we provide access to strategic corporates and financial investors in Europe, North America and Asia-Pacific. Our international roots are a key enabler when executing cross-border transactions successfully. NDA protocols signed before the first contact, anonymised infoMemo in the teaser phase, tiered data room access and explicit owner approval before revealing the company's identity to any candidate. Internal policies audited every 12 months. We determine your company's intrinsic value by applying proven valuation methodologies, while price can differ, since a buyer-investor's offer is shaped by factors such as: strategic fit and importance to their own business, the perception of competing with other potential buyer-investors in the process, the pursuit of economies of scale, among others. Let's talk ## Ready to _sell_, _buy_ or _grow_? A confidential first conversation, no commitment, with a founding partner. [Office Rambla de Catalunya 123, 4º-1ª, 08008 Barcelona](https://maps.google.com/?q=Rambla+de+Catalunya+123,+08008+Barcelona) [Phone (+34) 933 554 973](tel:+34933554973) [Email info@dextracorporate.com](mailto:info@dextracorporate.com) Office _Barcelona._ Direct attention Monday to Friday. Phone [(+34) 933 554 973](tel:+34933554973) Email [info@dextracorporate.com](mailto:info@dextracorporate.com) Address Rambla de Catalunya 123, 4th floor 08008 Barcelona